Victoria Steiner
San Francisco
Summary
Dynamic communications and investor relations leader, recognized for driving significant capital raises and successful product launches in the healthcare sector. Expertise in crafting compelling narratives that resonate with diverse audiences, facilitating strategic partnerships, and enhancing corporate reputation during critical milestones.
Overview
15
15
years of professional experience
Work History
Director, Communications & Media
CYTOKINETICS
01.2024 - Current
- Market Shaping: Leading brand communications and strategic global media relations to elevate disease and brand awareness among physicians, payors, and patients, securing top-tier coverage for late-stage clinical data.
- Architected proactive media and communications framework for premier cardiovascular franchise, ensuring readiness for high-stakes 2025 cardiac medicine launch in U.S., Europe, and China.
- Scientific Narrative: Translating sophisticated muscle biology data into impactful 'Cytokinetics stories' for major medical meetings (e.g., ACC, AHA) and scientific forums.
- Developed scenario planning and reactive messaging frameworks to safeguard corporate reputation during pivotal regulatory and clinical milestones.
Strategic Advisor
COMMUNICATIONS CONSULTANCY
01.2023 - 01.2024
- Advised biotech and AI-driven health tech firms on corporate roadmaps and integrated AI in healthcare (Stanford Cert) into technical data storytelling to enhance decision-making processes.
- Analyzed market trends to inform client strategies and recommendations.
- Developed strategic communication plans for diverse client needs.
- Collaborated with cross-functional teams to enhance service delivery.
Vice President, Communications
BLUESTAR GENOMICS / CLEARNOTE HEALTH
01.2021 - 01.2023
- Designed end-to-end communications strategy for breakthrough epigenomic technology, bridging the gap between R&D and commercial viability.
- Capital Acquisition: Spearheaded IR content and CEO presentations that directly facilitated a >$70M capital raise.
- Built patient advocacy programs that secured technology endorsements and accelerated clinical trial enrollment.
Director / Head of Communications
SYNTHEGO
01.2019 - 01.2021
- Series D Execution: Collaborated with Executive Team to shape corporate narrative that attracted $100M in Series D funding.
- Visibility Breakthrough: Secured the company’s inaugural presentation slot at the J.P. Morgan Healthcare Conference, significantly elevating its profile among institutional investors.
- Crisis Leadership: Led pandemic-era internal and external communications, maintaining business continuity and prioritizing employee safety.
Director, Product Communications & Media Relations
GENOMIC HEALTH
01.2011 - 01.2019
- Steered communications during 4x organizational growth and international launch of five-product oncology franchise, enhancing global brand presence.
- Managed multi-million dollar PR budgets and collaborated with global agency partners to ensure message precision across North America, Europe, and Asia, strengthening brand integrity.
- Led strategic initiatives to enhance genomic testing services and patient outcomes.
- Collaborated with cross-functional teams to develop innovative healthcare solutions.
- Managed budgets and resources for multiple projects within the organization.
Education
Master of Public Administration -
San Jose State University
San Jose, CABachelor of Arts - Communications
University of California, Berkeley
Berkeley, CAAI in Healthcare Specialization -
Stanford University
Palo Alto, CASkills
- Crisis communications
- Strategic communications
- Corporate communications
- Media relations
- Investor relations
- Content strategy
- Data storytelling
- Cross-functional leadership
- Stakeholder engagement
- Leadership communications
- Team building
- Effective collaboration
- Sector versatility
Education And Affiliations
- AI in Healthcare Specialization, Stanford University
- Master of Public Administration (MPA), San Jose State University
- Bachelor of Arts in Communications, University of California, Berkeley
- Advisory Council, California State University, Women in Leadership
- Committee Member, Doctors Without Borders (MSF), PR Advisory Committee
Executive Profile - Summary
Strategic Communications & Investor Relations Leader with 15+ years of experience driving brand identity and market value for high-growth biotech and healthcare organizations. Expert in translating complex science into compelling narratives across diagnostics, therapeutics, and vaccines. Proven track record of partnering with C-suite executives to navigate $100M+ capital raises, global product launches, and complex regulatory environments.
Timeline
Director, Communications & Media
CYTOKINETICS
01.2024 - Current
Strategic Advisor
COMMUNICATIONS CONSULTANCY
01.2023 - 01.2024
Vice President, Communications
BLUESTAR GENOMICS / CLEARNOTE HEALTH
01.2021 - 01.2023
Director / Head of Communications
SYNTHEGO
01.2019 - 01.2021
Director, Product Communications & Media Relations
GENOMIC HEALTH
01.2011 - 01.2019
Master of Public Administration -
San Jose State University
Bachelor of Arts - Communications
University of California, Berkeley
AI in Healthcare Specialization -
Stanford University